JPRN-UMIN000008321已完成未知
Prospective randomized trial for optimizing medical therapy after coronary stenitng - Calcium-Beta
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Stent restenosis or previous bypass surgery. 2.Previous diagnosis of vasospasmic angina within 1 years and/or on treatment. 3.Previous PCI within 1 years. 4.An event of acute myocardial infarction within 7 days. 5.Left main disease. 6.Left ventricular ejection fraction of less than 35%. 7.Previous Pacemaker Implant or AV block of more than 1st degree. 8.SBP less than 100 or HR less than 60 prior to PCI. 9.Renal failure (Cr more than 2.0mg/dl or on hemodialysis) 10.Liver failure (eg. cirrhosis) 11.Reversible obstructive lung disease 12.Diagnosis of malignancy within 5 years 13.Pregnancy
研究者
相似试验
已完成
4 期
Randomized clinical trial of the optimization of procedural pain control in ICU patientsNL-OMON31005Sint Antonius Ziekenhuis150
进行中（未招募）
不适用
Randomized clinical trial of the optimization of procedural pain control in Intensive Care patients - OPCICall patients admitted to the ICU of the St. Antonius hospital (>18 years old)EUCTR2007-003722-18-NLSt. Antonius Ziekenhuis
招募中
4 期
Prospective randomized trial to establish the optimal treatment regimen of rituximab for adult patients with steroid dependent and frequent-relapsing or steroid resistant nephrotic syndrome.ephrotic syndromeJPRN-UMIN000019844Osaka General Medical Center64
招募中
2 期
PICASSO. Prospective randomIzed clinical trial assessing the tolerance and clinical benefit of feCAl tranSplantation in patientS with melanOma treated with CTLA-4 and PD-1 inhibitorsMelanoma2024-516100-42-00Assistance Publique Hopitaux De Paris70
进行中（未招募）
1 期
Prospektiv randomisierte Studie zur Therapieoptimierung (Primärtherapie) fortgeschrittener progredienter follikulärer und anderer niedrig maligner sowie Mantelzell LymphomeTherapieoptimierung (Primärtherapie) fortgeschrittener progredienter follikülärer und anderer niedrigmaligner sowie Mantelzell LymphomeMedDRA version: 23.0Level: LLTClassification code 10029635Term: Non-Hodgkin's lymphoma unspecified histology low grade stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 23.0Level: LLTClassification code 10066703Term: Non-Hodgkin's lymphoma progressionSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 23.0Level: LLTClassification code 10029632Term: Non-Hodgkin's lymphoma unspecified histology low grade stage ISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 23.0Level: LLTClassification code 10029633Term: Non-Hodgkin's lymphoma unspecified histology low grade stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 23.0Level: LLTClassification code 10029634Term: Non-Hodgkin's lymphoma unspecified histology low grade stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2008-005859-16-ATStiL Forschungs-GmbH1,272